Indefinite Delivery Contract EPD10069

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency, has awarded an indefinite delivery contract (IDC) worth up to $48,622,546 to Charles River Laboratories, Inc. to provide safety evaluation and toxicology studies and related services to support drug development. The contract has a period of performance from August 2024 to August 2030. Under this IDC, Charles River will perform in vitro and in vivo exploratory and Investigational New Drug (IND)-directed...

The National Institute of Environmental Health Sciences, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a single-award indefinite delivery contract to Steinbeis GMBH & CO. KG FUR Technologietransfer with a potential value of $275,000. Under this contract, Steinbeis is providing human neural crest cell migration assay services in support of the agency's efforts to identify environmental compounds with potential for developmental...

The key products and services being delivered under this federal contract IDV award from the National Cancer Institute (NCI) are preclinical toxicology studies on small molecule drug candidates for cancer and other indications. The prime contractor, IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, will conduct non-GLP and GLP toxicology assessments in mice and dogs to support Investigational New Drug (IND) applications. IITRI holds several significant IDIQ...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology...

The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity contract to the University of Illinois with a potential value of $174.47 million. The contract supports the Pharmacology and Toxicology for Therapeutics Program, which aims to advance promising new treatments through preclinical testing. Under the contract, the University of Illinois will provide management and operations support services, as well as...

The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite delivery/indefinite quantity contract to IIT Research Institute of Chicago, Illinois with a potential value of $174,470,000. The contract aims to procure pharmacology and toxicology services to support the Pharmacology and Toxicology for Therapeutics Program. Services include non-GLP ADME/PK/TOX studies for up to 10 projects annually, GLP enabling toxicology studies for up to 5...

This Indefinite Delivery Contract is a parent IDIQ vehicle awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ has a total potential value of $174,470,000 and a period of performance through September 12, 2026. Under this IDIQ, Southern Research has been awarded multiple task orders to provide drug discovery,...

This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $48.6 million multiple-award IDC has a 6-year ordering period from June 2024 to June 2030. The contract aims to procure safety evaluation and toxicology studies and related services to support drug development efforts at NCATS....

The National Institutes of Health National Institute of Environmental Health Sciences awarded a single award indefinite delivery contract to IUF - Leibniz-Institut Fur Umweltmedizinische Forschung GMBH for human neurosphere assay services and related products. The contract has a potential value of $1.3 million and a period of performance through June 2026. Two firm fixed price delivery orders have been awarded against the contract to date, for $406,412.40 and $369,796.88 respectively, to provide...